This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/pharmgkb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/company/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/kegg-drug/
n14http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04465/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04465
rdf:type
n3:Drug
n3:description
A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. [PubChem]
n3:group
experimental
owl:sameAs
n14:DB04465 n16:DB04465
dcterms:title
Lactose
adms:identifier
n6:PA450161 n8:LAT n9:C00243 n10:D00046 n11:36219 n12:DB04465
n3:packager
n7:271B5C63-363D-11E5-9242-09173F13E4C5 n7:271B5C62-363D-11E5-9242-09173F13E4C5
n3:synthesisReference
James P. Danehy, "Synthesis of ascorbic acid from lactose." U.S. Patent US4259443, issued December, 1956.
n3:IUPAC-Name
n4:271B5C68-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5C6E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5C6D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5C6A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5C6B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5C6C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5C66-363D-11E5-9242-09173F13E4C5 n4:271B5C7E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5C67-363D-11E5-9242-09173F13E4C5 n4:271B5C64-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5C65-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5C74-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5C75-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5C6F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5C70-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5C72-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5C71-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5C73-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
63-42-3
n3:Bioavailability
n4:271B5C7A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5C7C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5C7D-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5C7F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5C79-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5C78-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5C7B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5C69-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5C76-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5C77-363D-11E5-9242-09173F13E4C5